Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Investment
Features
FeesSafety
Academy
More
Pluang+

Compare ADMA Biologics Inc (ADMA) vs Marathon Digital Holdings Inc (MARA) Price & Performance

ADMA Biologics Inc
Marathon Digital Holdings Inc

Price performance

Price movement over the last 24 hours

Key statistics

ADMA Biologics Inc vs Marathon Digital Holdings Inc — how do they compare? ADMA Biologics Inc trades at $9.22 (market cap $2.13B), while Marathon Digital Holdings Inc trades at $11.78 (market cap $4.59B). The key difference: Marathon Digital Holdings Inc is far larger — about 2.2× ADMA Biologics Inc's market cap, and Marathon Digital Holdings Inc is trading nearer its 52-week high, ADMA Biologics Inc nearer its low. Which is the better fit depends on your goals.

ADMAMARA
Market Cap
$2.13B$4.59B
Sector
HealthTechnology
52-Week High
$20.38$22.84
52-Week Low
$7.60$6.73
Enterprise Value
$2.20B$6.54B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

ADMA Biologics Inc

ADMA trades at $9.16, up 2.35% today, with a bullish technical signal from moving averages and oscillators. The company reported strong profitability with a 32.43% net income margin and 43.3% ROE for 2025, though recent EPS results were mixed. Analyst consensus is strongly bullish with an $19.00 price target, but multiple class action lawsuits filed in July 2026 alleging securities fraud create significant near-term uncertainty.

The stock offers substantial upside to analyst targets if legal challenges are resolved favorably, supported by robust fundamentals and projected cash flow growth. Primary risks include the outcome of ongoing litigation and potential reputational damage. Investors should weigh strong financial performance against elevated legal and sentiment risks before establishing a position.

Marathon Digital Holdings Inc

MARA Holdings trades at $12.95, up 4.44% today, but faces significant fundamental challenges with a net income margin of -234.83% and three consecutive quarterly earnings misses. The technical picture remains bearish with key resistance at $13-$14, while analyst sentiment is mixed with a 50% buy rating but a consensus price target of $16.60. Recent developments include the shipment of a hybrid energy storage prototype system from TAE Power Solutions (PRNewsWire, June 30, 2026) and ongoing pivot toward AI infrastructure.

Despite the bullish analyst consensus and potential from AI infrastructure expansion, MARA faces substantial execution risks amid persistent losses and negative cash flow from operations. The stock's valuation appears attractive on P/E (3.37) and EV/EBITDA (3.31) metrics, but profitability concerns and Bitcoin market volatility create significant downside risk for investors.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About ADMA Biologics Inc

ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.

Read more on ADMA

About Marathon Digital Holdings Inc

Marathon Digital Holdings, Inc. is one of the largest publicly traded Bitcoin mining companies in North America. The company focuses on building and operating large-scale, cost-efficient Bitcoin mining facilities. Marathon's strategy centers on increasing its mining hash rate and using sustainable energy sources to expand its Bitcoin production. The company's performance is closely tied to the price of Bitcoin and the overall health of the digital asset mining industry.

Read more on MARA